Metabolic switch from fatty acid oxidation to glycolysis in knock‐in mouse model of Barth syndrome

Mitochondria are central for cellular metabolism and energy supply. Barth syndrome (BTHS) is a severe disorder, due to dysfunction of the mitochondrial cardiolipin acyl transferase tafazzin. Altered cardiolipin remodeling affects mitochondrial inner membrane organization and function of membrane proteins such as transporters and the oxidative phosphorylation (OXPHOS) system. Here, we describe a mouse model that carries a G197V exchange in tafazzin, corresponding to BTHS patients. TAZG197V mice recapitulate disease-specific pathology including cardiac dysfunction and reduced oxidative phosphorylation. We show that mutant mitochondria display defective fatty acid-driven oxidative phosphorylation due to reduced levels of carnitine palmitoyl transferases. A metabolic switch in ATP production from OXPHOS to glycolysis is apparent in mouse heart and patient iPSC cell-derived cardiomyocytes. An increase in glycolytic ATP production inactivates AMPK causing altered metabolic signaling in TAZG197V . Treatment of mutant cells with AMPK activator reestablishes fatty acid-driven OXPHOS and protects mice against cardiac dysfunction.

[1]  W. Pu,et al.  Genetic modifiers modulate phenotypic expression of tafazzin deficiency in a mouse model of Barth syndrome. , 2023, Human Molecular Genetics.

[2]  Jennifer Veevers,et al.  Barth Syndrome Cardiomyopathy: An Update , 2022, Genes.

[3]  S. Miyamoto,et al.  Long‐chain fatty acid oxidation and respiratory complex I deficiencies distinguish Barth Syndrome from idiopathic pediatric cardiomyopathy , 2021, Journal of inherited metabolic disease.

[4]  Yusu Gu,et al.  Cardiolipin Remodeling Defects Impair Mitochondrial Architecture and Function in a Murine Model of Barth Syndrome Cardiomyopathy , 2021, Circulation. Heart failure.

[5]  R. Tian,et al.  Cardiac Energy Metabolism in Heart Failure , 2021, Circulation research.

[6]  Vassilios J. Bezzerides,et al.  Increased Reactive Oxygen Species–Mediated Ca2+/Calmodulin-Dependent Protein Kinase II Activation Contributes to Calcium Handling Abnormalities and Impaired Contraction in Barth Syndrome , 2021, Circulation.

[7]  O. Shirihai,et al.  Measuring Mitochondrial Respiration in Previously Frozen Biological Samples , 2020, Current protocols in cell biology.

[8]  Jan Dudek,et al.  Metabolic and Redox regulation of cardiovascular stem cell biology and pathology. , 2020, Antioxidants & redox signaling.

[9]  M. Gossen,et al.  Efficient generation of osteoclasts from human induced pluripotent stem cells and functional investigations of lethal CLCN7‐related osteopetrosis , 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  A. Heuberger,et al.  Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria , 2020, The Journal of Biological Chemistry.

[11]  L. Cyganek,et al.  Subtype-Directed Differentiation of Human iPSCs into Atrial and Ventricular Cardiomyocytes , 2020, STAR protocols.

[12]  Á. Ortega,et al.  PGC-1α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism , 2020, Oxidative medicine and cellular longevity.

[13]  Vassilios J. Bezzerides,et al.  AAV Gene Therapy Prevents and Reverses Heart Failure in a Murine Knockout Model of Barth Syndrome , 2020, Circulation research.

[14]  B. Byrne,et al.  Myocardial glucose and fatty acid metabolism is altered and associated with lower cardiac function in young adults with Barth syndrome , 2019, Journal of Nuclear Cardiology.

[15]  M. Schlame,et al.  A Critical Appraisal of the Tafazzin Knockdown Mouse Model of Barth Syndrome: What Have We Learned About Pathogenesis and Potential Treatments? , 2019, American journal of physiology. Heart and circulatory physiology.

[16]  J. Finsterer.  Barth syndrome: mechanisms and management , 2019, The Application of Clinical Genetics.

[17]  Jing Wang,et al.  WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs , 2019, Nucleic Acids Res..

[18]  B. Byrne,et al.  Blunted fat oxidation upon submaximal exercise is partially compensated by enhanced glucose metabolism in children, adolescents, and young adults with Barth syndrome , 2019, Journal of inherited metabolic disease.

[19]  Jan Dudek,et al.  The role of mitochondrial cardiolipin in heart function and its implication in cardiac disease. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[20]  Han-Ming Shen,et al.  Critical role of AMPK in redox regulation under glucose starvation , 2019, Redox biology.

[21]  Christopher S. Hughes,et al.  Single-pot, solid-phase-enhanced sample preparation for proteomics experiments , 2018, Nature Protocols.

[22]  S. Rizzoli,et al.  Defective Mitochondrial Cardiolipin Remodeling Dampens HIF-1α Expression in Hypoxia , 2018, Cell reports.

[23]  B. Viollet,et al.  AMPK Activation Reduces Hepatic Lipid Content by Increasing Fat Oxidation In Vivo , 2018, International journal of molecular sciences.

[24]  G. Lopaschuk,et al.  Loss of Metabolic Flexibility in the Failing Heart , 2018, Front. Cardiovasc. Med..

[25]  H. Broxmeyer,et al.  Patient-Tailored Mouse Genome Editing Recapitulates Hematopoietic and Systemic Manifestations of Barth Syndrome , 2017 .

[26]  Sheng-Cai Lin,et al.  AMPK: Sensing Glucose as well as Cellular Energy Status. , 2017, Cell metabolism.

[27]  G. Lopaschuk,et al.  028The contribution of fatty acid and ketone body oxidation to energy production increases in the failing heart and is associated with a decrease in cardiac efficiency , 2017 .

[28]  A. Shevchenko,et al.  Intensity-Independent Noise Filtering in FT MS and FT MS/MS Spectra for Shotgun Lipidomics. , 2017, Analytical chemistry.

[29]  M. Young,et al.  Metabolic Origins of Heart Failure , 2017, JACC. Basic to translational science.

[30]  Jan Dudek,et al.  Barth syndrome cardiomyopathy , 2017, Cardiovascular research.

[31]  Jüergen Cox,et al.  The MaxQuant computational platform for mass spectrometry-based shotgun proteomics , 2016, Nature Protocols.

[32]  K. Margulies,et al.  Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure , 2016, Circulation.

[33]  R. Wanders,et al.  Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome , 2015, EMBO molecular medicine.

[34]  Evan G. Williams,et al.  Tetracyclines Disturb Mitochondrial Function across Eukaryotic Models: A Call for Caution in Biomedical Research. , 2015, Cell reports.

[35]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[36]  B. Kemp,et al.  Enhanced activation of cellular AMPK by dual-small molecule treatment: AICAR and A769662. , 2014, American journal of physiology. Endocrinology and metabolism.

[37]  David A. Scott,et al.  Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.

[38]  G. Lopaschuk,et al.  Cardiac Insulin-Resistance and Decreased Mitochondrial Energy Production Precede the Development of Systolic Heart Failure After Pressure-Overload Hypertrophy , 2013, Circulation. Heart failure.

[39]  R. Wanders,et al.  Cardiolipin deficiency affects respiratory chain function and organization in an induced pluripotent stem cell model of Barth syndrome. , 2013, Stem cell research.

[40]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[41]  W. Shi,et al.  The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote , 2013, Nucleic acids research.

[42]  A. Shaywitz,et al.  AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. , 2013, Molecular cell.

[43]  G. Lopaschuk,et al.  Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload. , 2013, Cardiovascular research.

[44]  Y. Huang,et al.  Diminished Exercise Capacity and Mitochondrial bc1 Complex Deficiency in Tafazzin-Knockdown Mice , 2013, Front. Physiol..

[45]  E. Bertini,et al.  New clinical and molecular insights on Barth syndrome , 2013, Orphanet Journal of Rare Diseases.

[46]  M. Ashworth,et al.  Barth syndrome , 2013, Orphanet Journal of Rare Diseases.

[47]  E. Shoubridge,et al.  MITRAC Links Mitochondrial Protein Translocation to Respiratory-Chain Assembly and Translational Regulation , 2012, Cell.

[48]  Michael Schroeder,et al.  LipidXplorer: A Software for Consensual Cross-Platform Lipidomics , 2012, PloS one.

[49]  R. Shaw,et al.  The AMPK signalling pathway coordinates cell growth, autophagy and metabolism , 2011, Nature Cell Biology.

[50]  Ronald J. Moore,et al.  Reversed‐phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells , 2011, Proteomics.

[51]  M. Mann,et al.  Software Lock Mass by Two-Dimensional Minimization of Peptide Mass Errors , 2011, Journal of the American Society for Mass Spectrometry.

[52]  Stefan R Bornstein,et al.  A novel informatics concept for high-throughput shotgun lipidomics based on the molecular fragmentation query language , 2011, Genome Biology.

[53]  J. Wansapura,et al.  Cardiac and Skeletal Muscle Defects in a Mouse Model of Human Barth Syndrome* , 2010, The Journal of Biological Chemistry.

[54]  Stacey M Smith,et al.  Assembly of nuclear DNA‐encoded subunits into mitochondrial complex IV, and their preferential integration into supercomplex forms in patient mitochondria , 2009, The FEBS journal.

[55]  Ashim Malhotra,et al.  Distinct effects of tafazzin deletion in differentiated and undifferentiated mitochondria. , 2009, Mitochondrion.

[56]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[57]  J. Ingwall.  Energy metabolism in heart failure and remodelling. , 2008, Cardiovascular research.

[58]  N. Fujii,et al.  Discovery of TBC1D1 as an Insulin-, AICAR-, and Contraction-stimulated Signaling Nexus in Mouse Skeletal Muscle* , 2008, Journal of Biological Chemistry.

[59]  Stefan Neubauer,et al.  The failing heart--an engine out of fuel. , 2007, The New England journal of medicine.

[60]  L. Scorrano,et al.  Organelle isolation: functional mitochondria from mouse liver, muscle and cultured filroblasts , 2007, Nature Protocols.

[61]  Huiyun Liang,et al.  Staying Current PGC-1 : a key regulator of energy metabolism , 2006 .

[62]  L. Kifle,et al.  Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. , 2006, Cell metabolism.

[63]  J. Huss,et al.  Mitochondrial energy metabolism in heart failure: a question of balance. , 2005, The Journal of clinical investigation.

[64]  E. Dufour,et al.  A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[65]  P. Shannon,et al.  Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks , 2003 .

[66]  W. Giannobile,et al.  Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial Mechanisms , 1998, Advances in dental research.

[67]  J. Berden,et al.  An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes , 1983, Journal of the Neurological Sciences.

[68]  K. Pan,et al.  Relative Quantification of Phosphorylated and Glycosylated Peptides from the Same Sample Using Isobaric Chemical Labelling with a Two-Step Enrichment Strategy. , 2021, Methods in molecular biology.

[69]  Gang Wang,et al.  Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014 .

[70]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[71]  B. Brügger,et al.  Quantitative analysis of cellular lipids by nano-electrospray ionization mass spectrometry. , 2013, Methods in molecular biology.

[72]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[73]  A. Hermetter,et al.  Strategies for the synthesis of glycerophospholipids. , 1994, Progress in lipid research.

[74]  Andrew E. Jaffe,et al.  Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .